1. Shao, Z. et al. Dysregulated protocadherin-pathway activity as an intrinsic defect in induced pluripotent stem cell-derived cortical interneurons from subjects with schizophrenia. Nature Neuroscience (2019).
|
2. Ni, P. et al. iPSC-derived homogeneous populations of developing schizophrenia cortical interneurons have compromised mitochondrial function. Molecular Psychiatry (2019).
|
3. Warren and Lin. "mRNA-Based Genetic Reprogramming." Molecular Therapy (2018).
|
4. Schlaeger et al. "A comparison of non-integrating reprogramming methods." Nature Biotechnology (2014).
|
5. Durruthy-Durruthy et al. "Rapid and efficient conversion of integration-free human induced pluripotent stem cells to GMP-grade culture conditions." PLOS ONE (2014).
|
6. Steichen et al. "Messenger RNA versus retrovirus-based induced pluripotent stem cell reprogramming strategies: analysis of genomic integrity." Stem Cells Translational Medicine (2014).
|
7. Boreström et al. "Footprint-free human induced pluripotent stem cells from articular cartilage with redifferentiation capacity: a first step toward a clinical-grade cell source."
Stem Cells Translational Medicine (2014).
|
8. Warren et al. "Feeder-free derivation of human induced pluripotent stem cells with messenger RNA." Scientific Reports (2012).
|
9. Warren et al. "Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA." Cell Stem Cell (2010).
|